Post-PCI AKI Not Linked to Contrast ...

Development of acute kidney injury (AKI) following primary percutaneous coronary intervention (PCI) is not related to the use of contrast media, but rather to factors such as older age and hemodynamic instability, according to a new study.

RP May Not Offer Survival Advantage

Men with localized prostate cancer (PCa) treated with radical prostatectomy (RP) survive no longer than those undergoing observation, according to study results from PIVOT (Prostate Cancer Intervention versus Observation Trial) published in the New England Journal of Medicine.

Optimal Iron for HD Patients Reported

Researchers have identified what they conclude is the optimal iron status for hemodialysis (HD) patients receiving erythropoietin treatment, according to study findings.

What Not to Eat After Nephrectomy

In the past, doctors may have reassured kidney donors that they are not at higher risk of ESRD. Today, it would be naïve for physicians to believe that patients with a solitary kidney after nephrectomy do not have a serious condition and do not need dietary advice or diet and lifestyle modification.

Training Staff in HIPAA Regulations

Most breaches of protected health information are related to human error, underscoring the need for medical practices to develop and maintain rigorous training programs for employees so they comply with HIPAA regulations.

CKD-MBD Guidelines Updated

A Kidney Disease: Improving Global Outcomes (KDIGO) work group has just released an update of the KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD).

Robotic, Open RC Offer Similar Results

Robot-assisted radical cystectomy (RARC) and open radical cystectomy (ORC) for muscle-invasive or high-risk non-muscle invasive bladder cancer are associated with similar outcomes, but RARC might have some advantages, a new literature review suggests.

Tips for Negotiating Payer Contracts

Depending upon Congress' actions in the coming year, the insurance industry may be an entirely new landscape in 2018. But that does not mean providers should be satisfied with payers' rates and terms. Familiarity with current contracts and knowing how to negotiate better ones will be crucial to boosting income.

TERT May Detect Bladder Cancer Recurrence

A non-invasive urinary test for telomerase reverse transcriptase (TERT) promoter mutations may identify recurrent urothelial bladder cancer (UBC) earlier than standard cytology and cystoscopy, a new study finds.

Looking for a Job?

Access our job board to view over 1,000 job openings throughout the US.

RUN Social Media Survey

Tell us about your social media habits for a chance to win a free gift card.


Sign Up for Free e-newsletters